PRETREATMENT WITH THE 5-HT1A RECEPTOR AGONISTS 8-OH-DPAT OR GEPIRONE DOES NOT ATTENUATE THE INHIBITORY EFFECT OF SYSTEMICALLY ADMINISTERED CHOLECYSTOKININ (CCK) ON FOOD-INTAKE IN RATS
Is. Ebenezer et J. Brooman, PRETREATMENT WITH THE 5-HT1A RECEPTOR AGONISTS 8-OH-DPAT OR GEPIRONE DOES NOT ATTENUATE THE INHIBITORY EFFECT OF SYSTEMICALLY ADMINISTERED CHOLECYSTOKININ (CCK) ON FOOD-INTAKE IN RATS, Methods and findings in experimental and clinical pharmacology, 16(8), 1994, pp. 589-595
In order to investigate whether the inhibitory effect of systemically
administered cholecystokinin (CCK) on food intake is dependent on an i
nteraction with central 5-hydroxytryptamine (5-HT) processes, we exami
ned the effects of pretreating rats that were deprived of food for var
ious periods of time (22 h in Experiments 1 and 3, 3 h in Experiment 2
, and 1 h in Experiment 4) with the 5-HT1A receptor agonists, 8-OH-DPA
T or gepirone, on the suppression of feeding induced by intraperitonea
l CCK. 8-OH-DPAT(100 mu g/kg, Experiments 1 and 2) or gepirone (2 mg/k
g, Experiments 3 and 4) administered subcutaneously 60 min prior to in
traperitoneal injection of CCK (6 mu g/kg) did not attenuate the suppr
essant effect of CCK on feeding in any of these experiments. The 5-HT1
A agonists had no significant effects on food intake on their own. As
it has been established that the doses of 8-OH-DPAT and gepirone used
in this study decrease 5-HT function in the central nervous system, th
e present results indicate that it is unlikely that the inhibitory eff
ect of systemically administered CCK on food intake is dependent on an
interaction with intact central 5-HT systems.